Cancer

Items 191-200 of 433

per page
Set Descending Direction
  1. DLK1, Soluble (human) ELISA Kit
    AG-45A-0032Y
    AG-45A-0032YEK-KI0196 wells
    CHF 600.00
    Standardcurve
  2. DLL3 (human) (rec.)
    AG-40B-0151
    AG-40B-0151-C01010 µg
    CHF 215.00
    AG-40B-0151-30103 x 10 µg
    CHF 430.00
  3. DLL4 (human):Fc (human) (rec.) (highly active mutant)
    AG-40B-0176
    AG-40B-0176-C01010 µg
    CHF 350.00
    AG-40B-0176-C100100 µg
    CHF 1'080.00
    DLL4 (human):Fc (human) (rec.) (highly active mutant) (AG-40B-0176) binds to mNotch1 with higher affinity than WT DLL4:Fc. Method: Notch1 (mouse):Fc was coated on an ELISA plate at 1μg/ml. After blocking and washing steps, indicated concentrations
  4. DMAT
    CAS  749234-11-5
    AG-CR1-3654
    AG-CR1-3654-M0011 mg
    CHF 40.00
    AG-CR1-3654-M0055 mg
    CHF 160.00
    AG-CR1-3654-M02525 mg
    CHF 480.00
    DMAT
  5. DNER (extracellular domain) (human) (rec.)
    AG-40A-0137Y
    AG-40A-0137Y-C01010 µg
    CHF 265.00
    AG-40A-0137Y-30103 x 10 µg
    CHF 530.00
  6. DNER (extracellular domain) (human):Fc (human) (rec.)
    AG-40A-0119T
    AG-40A-0119T-C01010 µg
    CHF 170.00
    AG-40A-0119T-C05050 µg
    CHF 470.00
  7. DNER (extracellular domain) (mouse):Fc (human) (rec.)
    AG-40A-0177
    AG-40A-0177-C01010 µg
    CHF 230.00
    AG-40A-0177-C05050 µg
    CHF 685.00
  8. DPVP (Resveratrol Analog)
    CAS  1462947-40-5 | 223386-36-5
    AG-CR1-3604
    AG-CR1-3604-M0011 mg
    CHF 170.00
    DPVP (Resveratrol Analog)
  9. Ds(+)-threo-Isocitric acid . trisodium salt
    CAS  903507-52-8 | Free Acid: 6061-97-8
    AG-CR1-3505
    AG-CR1-3505-M02525 mg
    CHF 80.00
    AG-CR1-3505-M100100 mg
    CHF 240.00
    AG-CR1-3505-G0011 g
    CHF 1'680.00
    Ds(+)-threo-Isocitric acid . trisodium salt
  10. Ecdysterone
    CAS  5289-74-7
    CDX-E0225
    CDX-E0225-M0055 mg
    CHF 95.00
    CDX-E0225-M02525 mg
    CHF 285.00
    Ecdysterone

Items 191-200 of 433

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.